Literature DB >> 28007294

[The frequency of cancer in France: Most recent data and trends].

Laureen Ribassin-Majed1, Gwénaël Le-Teuff1, Catherine Hill2.   

Abstract

We present and discuss recent data on the frequency of cancer in France and on cancer survival. In the male population, the incidence of prostate and head and neck cancers diminishes rapidly and the incidence of the other common cancers: lung and colorectal diminishes less markedly; cancer mortality decreases for most sites. In the female population, the incidence of breast cancer diminishes rapidly, the incidence of colorectal and uterus cancers diminish less markedly and the incidence of lung cancer increases very fast: the mortality trends are similar. Cancer survival has improved in the last 16 years but some of the improvements are an artifact induced by overdiagnosis.
Copyright © 2016 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Epidemiology; France; Incidence; Mortality; Mortalité; Survie; Survival; Épidémiologie

Mesh:

Year:  2016        PMID: 28007294     DOI: 10.1016/j.bulcan.2016.11.003

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer.

Authors:  Aliyah M Weinstein; Nicolas A Giraldo; Florent Petitprez; Catherine Julie; Laetitia Lacroix; Frédérique Peschaud; Jean-François Emile; Laetitia Marisa; Wolf H Fridman; Walter J Storkus; Catherine Sautès-Fridman
Journal:  Cancer Immunol Immunother       Date:  2018-10-12       Impact factor: 6.968

2.  Diagnosis of advanced cervical cancer, missed opportunities?

Authors:  Jérémie Mattern; Irène Letendre; Jeanne Sibiude; Cécile Pénager; Asma Jnifen; Fatoumata Souare; Sophie Ayel; Thuy Nguyen; Laurent Mandelbrot
Journal:  BMC Womens Health       Date:  2022-03-30       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.